Current solutions developed for the purpose of in and on body (IOB) electrical stimulation
(ES) lack autonomous qualities necessary for comfortable, practical, and self‐dependent …

Triboelectric nanogenerators (TENGs) have gained significant traction in recent years in the
bioengineering community. With the potential for expansive applications for biomedical use …

Current therapeutic strategies such as angiogenic therapy and anti-inflammatory therapy for
treating myocardial infarction have limited success. An effective approach may benefit from …

The human heart is continually operating as a muscular pump, contracting, on average, 80
times per minute to propel 8000 liters of blood through body tissues each day. Whereas …

The burden of cardiovascular and metabolic diseases worldwide is staggering. The
emergence of systems approaches in biology promises new therapies, faster and cheaper …

Correlative evidence suggests that polyploidization of heart muscle, which occurs naturally
in post-natal mammals, creates a barrier to heart regeneration. Here, we move beyond a …

After decades of directed research, no effective regenerative therapy is currently available to
repair the injured human heart. The epicardium, a layer of mesothelial tissue that envelops …

Cardiomyocyte loss after injury results in adverse remodelling and fibrosis, inevitably
leading to heart failure. The ERBB2–Neuregulin and Hippo–YAP signalling pathways are …

Ischemic heart disease is the leading cause of death worldwide. Myocardial infarction
results in an irreversible loss of cardiomyocytes with subsequent adverse remodeling and …

Background: The inability of the adult mammalian heart to regenerate following injury
represents a major barrier in cardiovascular medicine. In contrast, the neonatal mammalian …